Medindia
Medindia LOGIN REGISTER
Advertisement

Drug-Eluting Stent Market in Brazil Limited Due to Lack of Reimbursement in the Public Healthcare System

Tuesday, June 29, 2010 General News
Advertisement
Brazil's Drug-Eluting Stent Penetration Rate Sits at 30 Percent while Other Emerging Markets are Much Higher, according to Millennium Research Group

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 ext. 101

[email protected]

Chris Comfort

Decision Resources Inc.

781-296-2597

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close